SEC Form 4 · accession 0000899243-18-017080
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendall Wierenga
Director
Period of report
Jun 14, 2018
Accepted (ET)
Jun 18, 2018 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (Right to Buy)F1 | $19.59 | Jun 14, 2018 | A | 10,000 | A | — | Jun 13, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019.